It does mean the science is moving toward a broader view of GLP-1s as metabolic regulators, not just obesity drugs
Across preclinical research and clinical studies, cagrilintide has been evaluated for effects on body weight, energy intake, and metabolic parameters, including work that explores combination approaches (such as pairing with semaglutide)
Rotate Injection Sites: Injecting the medication into different areas (your stomach, thigh, or upper arm) can prevent skin irritation and sometimes mildly alter how the medication is absorbed, which some patients report helps with GI symptoms
"Obesity and being overweight are definitely risk factors for multiple adverse outcomes in pregnancy," said Dr
F.BrownM.SanchezE.TattersallR